MedTrace Logo

AQP-1 Polymorphism on Fluid Status in Hemodialysis Patients

NCT05275387 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2022-11-01

No results posted yet for this study

Summary

It is a cross sectional observational study. It is to investigate whether AQP-1 polymorphism has any impact on fluid status in hemodialysis patients. The long term stable HD patients in the current center will be enrolled to the study after informed consent. Blood samples will be collected for gene-typing. Fluid status including blood pressure, weekly UF and intra-dialysis body weight change will be collected through their clinical records.

Conditions

  • End Stage Renal Disease on Dialysis

Interventions

OTHER

observational study, no intervention

observational study, no intervention

Sponsors & Collaborators

  • RenJi Hospital

    lead OTHER

Principal Investigators

  • Zanzhe Yu, PhD · RenJi Hospital

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-01
Primary Completion
2023-01-30
Completion
2023-02-28

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05275387 on ClinicalTrials.gov